Citius Oncology (CTOR) Total Current Liabilities (2021 - 2026)

Citius Oncology's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $58.8 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 18.24% year-over-year to $58.8 million; the TTM figure through Mar 2026 stood at $58.8 million (up 18.24% YoY), while the FY2025 annual figure was $49.5 million, up 51.35% from the prior year.
• Total Current Liabilities was $58.8 million for Q1 2026 at Citius Oncology, up from $44.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $58.8 million in Q1 2026 to a low of $31836.0 in Q4 2022.
• Historically, Total Current Liabilities has averaged $24.1 million across 5 years, with a median of $21.0 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities tumbled 76.68% in 2022, then surged 7787.05% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $31836.0 in 2022, then soared by 6325.94% to $2.0 million in 2023, then jumped by 2021.44% to $43.4 million in 2024, then advanced by 3.02% to $44.7 million in 2025, then surged by 31.54% to $58.8 million in 2026.
• The last three Total Current Liabilities figures came in at $58.8 million (Q1 2026), $44.7 million (Q4 2025), and $49.5 million (Q3 2025), per Business Quant data.